First-quality medical writing
About medical writing and writers
Journals are picky about which articles they accept, and your hard work can be refused no matter how ground-breaking your discoveries. A well-written publication, in impeccable English, often makes the difference. Keep in mind the following...
1) Most interesting tool. Medical writing is so interesting because it inhabits a boundary zone between science and art. It must be factual and objective. Formulaic papers reporting data in a dispassionate manner tend to be dry. Good papers are persuasive. Yet, when the persuasive elements are taken too far, the report becomes biased…
2) Good judgment. The medical writer must answer the question: ‘What is the best way to present the research?’ Raw data often run to hundreds of pages. Here is where the medical writer steps in distilling the data into something readable. Which findings should be highlighted? Which might be omitted? All this calls for good judgment.
3) Clarity. Powerful communication requires simple messages. Scientists often complain that journalists oversimplify their messages. We should, however, learn from the journalists’ skills in elaborating readable and reader-centered messages.
4) Completeness. Conventional papers often neglect significant details. With the 3000-5000 word article as sound consensus, this is by no means perfect. We should not ignore alternative ways of providing information, such as websites, links to trial registers, etc.
5) Ask for help. We are here to lend you a hand. Tap your project’s full potential by sending us your manuscript!
Long-standing collaboration
We have been collaborating for several years with Professor Jacques Cadranel, Tenon Hospital, Paris, translating scientific papers into English, editing Letters to the Editor, or adapting publications to the Instructions for authors.
Over the last years, Prof. Jacques Cadranel, Paris, France, has entrusted us to edit or translate several papers focused on lung cancer therapy. This fascinating topic has pricked our attention immediately. Ongoing research in this domain is most promising!
Routine molecular profiling
Prof. Jacques Cardranel is particularly interested in routine molecular profiling of patients with non-small-cell lung cancer. This technology seeks to identify gene products as well as their mutations, which should allow us to predict tumor responses to targeted therapies like tyrosine kinase inhibitors. Results of a 1-year nationwide program have already been published and can be accessed under http://thelancet.com/journals/lancet/article/PIIS0140-6736(16)00004-0/fulltext.
Should this technology succeed in the forthcoming future, this would pave the way for an individualized lung cancer treatment approach, targeting the tumor, while leaving the healthy tissues and organs intact. This is a real opportunity for lung cancer patients worldwide.
Provide us with feedback
You have so far been sending us positive feedback as illustrated below, which of course helps boost our confidence!
- We were very satisfied with the quality and promptness of your services. It would have taken us weeks, even months…with less good results.
- A big thank you for this stunning performance. I was expecting high-quality English, but not that you would be able to handle, quite independently, the entire Discussion section.
Don’t be afraid to give us negative feedback. Constructive criticism would indeed enable us to further enhance our writing skills. Please e-mail us your concerns or suggestions at info@cremerconsulting.com